Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylation Detection of KCNA3 and OTOP2 Genes in Plasma for the Auxiliary Diagnosis of Hepatocellular Carcinoma: a Clinical Trial

NCT05668793 is registered in ClinicalTrials.gov with Wuhan Ammunition Life-tech Co., Ltd as lead sponsor.

NCT NCT05668793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05668793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylation Detection of KCNA3 and OTOP2 Genes in Plasma for the Auxiliary Diagnosis of Hepatocellular Carcinoma: a Clinical Trial
Lead sponsor
Wuhan Ammunition Life-tech Co., Ltd
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2023
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma